# The Role of Autophagy–Lysosomal Pathways in Photoreceptor Death in the rd10 Mouse Model of Inherited Retinal Degeneration

**Authors:** Kirstan A. Vessey, Nadia Hosseini Naveh, Ophelia Ehrlich, Allegra Glover, Joshua Lee, Ursula Greferath, Andrew I. Jobling, Erica L. Fletcher

PMC · DOI: 10.3390/cells15040345 · 2026-02-13

## TL;DR

This study explores how problems with cell waste disposal contribute to photoreceptor death in a mouse model of retinal degeneration, suggesting early treatment opportunities.

## Contribution

The study identifies early autophagy–lysosomal changes in photoreceptor degeneration, highlighting a potential therapeutic window.

## Key findings

- Autophagosome and autolysosome numbers increase in photoreceptor compartments before significant cell loss.
- Early downregulation of mTOR and upregulation of autophagy-related genes suggest initial autophagy induction.
- Progressive accumulation of unprocessed waste indicates overwhelmed cellular clearance capacity.

## Abstract

Inherited retinal degenerations, such as retinitis pigmentosa, are a leading cause of irreversible vision loss, yet broadly effective treatments remain elusive. Impaired cellular waste clearance via autophagy–lysosomal pathways have been implicated in photoreceptor death, but the spatiotemporal dynamics of these processes during degeneration remain poorly understood. Using the rd10 mouse model of retinitis pigmentosa, we characterised autophagy–lysosomal dysfunction at key stages of photoreceptor degeneration (postnatal day P17, P22, P35) through super-resolution imaging of RFP-EGFP-LC3 reporter mice, Western blot, and bulk RNA sequencing. Autophagosome and autolysosome numbers were significantly elevated across all photoreceptor compartments (inner/outer segments, outer nuclear layer, outer plexiform layer) at P17, prior to significant photoreceptor nuclei loss. Autophagosome and autolysosome size progressively increased from P22 onwards, suggesting accumulation of unprocessed intracellular waste. Molecular analyses revealed downregulation of mTOR protein, upregulation of autophagy-related genes, and increased lysosomal processes from P17. These histological and molecular findings are consistent with early autophagy induction followed by overwhelmed degradative capacity. Our findings identify autophagy–lysosomal change as an early event in photoreceptor loss in the rd10 model, revealing a critical therapeutic window for mutation-independent interventions targeting cellular clearance pathways in inherited retinal degenerations.

## Linked entities

- **Proteins:** MTOR (mechanistic target of rapamycin kinase)
- **Diseases:** retinitis pigmentosa (MONDO:0008377)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** RAB7B (RAB7B, member RAS oncogene family) [NCBI Gene 338382] {aka RAB7}, Ulk1 (unc-51 like kinase 1) [NCBI Gene 22241] {aka Unc51.1, mKIAA0722}, CTSS (cathepsin S) [NCBI Gene 1520], Map1lc3b (microtubule-associated protein 1 light chain 3 beta) [NCBI Gene 67443] {aka 1010001C15Rik, Atg8, LC3b, MAP1A/MAP1B, Map1lc3}, CTSD (cathepsin D) [NCBI Gene 1509] {aka CLN10, CPSD, HEL-S-130P}, Becn1 (beclin 1, autophagy related) [NCBI Gene 56208] {aka Atg6}, STX17 (syntaxin 17) [NCBI Gene 55014], Rab7 (RAB7, member RAS oncogene family) [NCBI Gene 19349] {aka Rab7a}, CHP1 (calcineurin like EF-hand protein 1) [NCBI Gene 11261] {aka CHP, SLC9A1BP, SPAX9, Sid470p, p22, p24}, Ctss (cathepsin S) [NCBI Gene 13040] {aka Cats}, Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, Ern1 (endoplasmic reticulum to nucleus signalling 1) [NCBI Gene 78943] {aka 9030414B18Rik, Ire1a, Ire1alpha, Ire1p}, STK11 (serine/threonine kinase 11) [NCBI Gene 6794] {aka LKB1, PJS, hLKB1}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, Ctsd (cathepsin D) [NCBI Gene 13033] {aka CD, CatD}, Ern2 (endoplasmic reticulum to nucleus signalling 2) [NCBI Gene 26918] {aka Ern1, Ire1, Ire1b, ire1-beta, mIre1}, Pde6b (phosphodiesterase 6B, cGMP, rod receptor, beta polypeptide) [NCBI Gene 18587] {aka Pdeb, r, rd, rd-1, rd1, rd10}, Map1lc3a (microtubule-associated protein 1 light chain 3 alpha) [NCBI Gene 66734] {aka 1010001H21Rik, 4922501H04Rik, LC3, LC3a}, Nbr1 (NBR1, autophagy cargo receptor) [NCBI Gene 17966] {aka mKIAA0049}, Pycard (PYD and CARD domain containing) [NCBI Gene 66824] {aka 9130417A21Rik, Asc, CARD5, TMS-1, TNS1, masc}, Pik3r1 (phosphoinositide-3-kinase regulatory subunit 1) [NCBI Gene 18708] {aka PI3K, p50alpha, p55alpha, p85alpha}, Dap (death-associated protein) [NCBI Gene 223453] {aka 4921531N22Rik}, Capn3 (calpain 3) [NCBI Gene 12335] {aka Capa-3, Capa3, Lp82, p94}, EIF4EBP1 (eukaryotic translation initiation factor 4E binding protein 1) [NCBI Gene 1978] {aka 4E-BP1, 4EBP1, BP-1, PHAS-I}, MAP1LC3A (microtubule associated protein 1 light chain 3 alpha) [NCBI Gene 84557] {aka ATG8E, LC3, LC3A, MAP1ALC3, MAP1BLC3}, Optn (optineurin) [NCBI Gene 71648] {aka 4930441O07Rik, FIP2, HYPL, NRP}, MAP3K7 (mitogen-activated protein kinase kinase kinase 7) [NCBI Gene 6885] {aka CSCF, FMD2, MEKK7, TAK1, TGF1a}, Usp13 (ubiquitin specific peptidase 13 (isopeptidase T-3)) [NCBI Gene 72607] {aka 2700071E21Rik, ISOT3, IsoT-3}, STX7 (syntaxin 7) [NCBI Gene 8417], S100a1 (S100 calcium binding protein A1) [NCBI Gene 20193] {aka S100, S100a}, Sqstm1 (sequestosome 1) [NCBI Gene 18412] {aka A170, OSF-6, Osi, STAP, STONE14, p62}, Capns1 (calpain, small subunit 1) [NCBI Gene 12336] {aka Capa-4, Capa4, Capn4, Cdps, Css1, D7Ertd146e}, Bid (BH3 interacting domain death agonist) [NCBI Gene 12122] {aka 2700049M22Rik}, Uvrag (UV radiation resistance associated gene) [NCBI Gene 78610] {aka 9530039D02Rik, Uvrag1, Uvragl}, Pvalb (parvalbumin) [NCBI Gene 19293] {aka PV, Parv, Pva}, Srpx (sushi-repeat-containing protein) [NCBI Gene 51795] {aka DRS-1, DRS-2, drs, drs-1, drs-2}, CTSL (cathepsin L) [NCBI Gene 1514] {aka CATL, CTSL1, MEP}, Orai3 (ORAI calcium release-activated calcium modulator 3) [NCBI Gene 269999] {aka 9930124N15, Tmem142c}, Lamp1 (lysosomal-associated membrane protein 1) [NCBI Gene 16783] {aka CD107a, LGP-120, LGP-A, Lamp-1, P2B, Perk}, Capn2 (calpain 2) [NCBI Gene 12334] {aka CALP80, Capa-2, Capa2, m-calpain, m-calpin}, Trp53 (transformation related protein 53) [NCBI Gene 22059] {aka Tp53, bbl, bfy, bhy, p44, p53}, S100a6 (S100 calcium binding protein A6 (calcyclin)) [NCBI Gene 20200] {aka 2A9, 5B10, CALCYCLIN, Cacy, PRA}, CTSB (cathepsin B) [NCBI Gene 1508] {aka APPS, CPSB, KWE, RECEUP}, Orai1 (ORAI calcium release-activated calcium modulator 1) [NCBI Gene 109305] {aka D730049H07Rik, Tmem142a, orai-1}, IGF1R (insulin like growth factor 1 receptor) [NCBI Gene 3480] {aka CD221, IGFIR, IGFR, JTK13}, Stk11 (serine/threonine kinase 11) [NCBI Gene 20869] {aka Lkb1, Par-4}, Mcub (mitochondrial calcium uniporter dominant negative beta subunit) [NCBI Gene 66815] {aka 9030408N13Rik, Ccdc109b}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, Rho (rhodopsin) [NCBI Gene 212541] {aka Noerg1, Opn2, Ops, RP4}, ERN1 (endoplasmic reticulum to nucleus signaling 1) [NCBI Gene 2081] {aka IRE1, IRE1P, IRE1a, hIRE1p}, CAMKK2 (calcium/calmodulin dependent protein kinase kinase 2) [NCBI Gene 10645] {aka CAMKK, CAMKKB}, Vamp8 (vesicle-associated membrane protein 8) [NCBI Gene 22320] {aka Edb, endobrevin}, Capn1 (calpain 1) [NCBI Gene 12333] {aka Capa-1, Capa1, mu-calpin}, Eif4ebp1 (eukaryotic translation initiation factor 4E binding protein 1) [NCBI Gene 13685] {aka 4e-bp1, PHAS-I}, Stx7 (syntaxin 7) [NCBI Gene 53331] {aka Syn7}, Casp1 (caspase 1) [NCBI Gene 12362] {aka ICE, Il1bc}, Mcur1 (mitochondrial calcium uniporter regulator 1) [NCBI Gene 76137] {aka 6230416A05Rik, Ccdc90a}, VAMP8 (vesicle associated membrane protein 8) [NCBI Gene 8673] {aka EDB, VAMP-8}, Mcu (mitochondrial calcium uniporter) [NCBI Gene 215999] {aka 2010012O16Rik, C10orf42, Ccdc109a, D130073L02Rik, Gm64}, PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}
- **Diseases:** rod degeneration (MESH:D000071700), lysosomal (MESH:D016464), age-related macular degeneration (MESH:D008268), photoreceptor loss (MESH:D016388), neurodegeneration (MESH:D019636), injury to (MESH:D014947), vision loss (MESH:D014786), OS (MESH:C567932), cellular dysfunction and (MESH:D004806), hypoxia (MESH:D000860), cone photoreceptor degeneration (MESH:C566719), damage (MESH:D020263), photo (MESH:D054039), autosomal recessive RP (MESH:D012174), Photoreceptor (MESH:D012173), CLN10 disease (MESH:C566438), Inherited retinal degenerations (MESH:D012162), Photoreceptor Death (MESH:D003643), dislocation (MESH:D004204), ONL (MESH:C538223), calcium (MESH:D002128), photoreceptor degeneration (MESH:D009410), IS (MESH:D007759), degenerative retinal disorders (MESH:D012164), OPL (MESH:D018318)
- **Chemicals:** xylazine (MESH:D014991), nitrogen (MESH:D009584), Rapamycin (MESH:D020123), cGMP (MESH:D006152), phosphate (MESH:D010710), SDS (MESH:D012967), bafilomycin A1 (MESH:C040929), Thiourea (MESH:D013890), Dithiothreitol (MESH:D004229), Laemmli buffer (MESH:C088816), acrylamide (MESH:D020106), metformin (MESH:D008687), Bisbenzimide (MESH:D006690), water (MESH:D014867), CHAPS (MESH:C028213), Hoechst 33342 (MESH:C017807), Urea (MESH:D014508), oil (MESH:D009821), BioRad (-), Spermidine (MESH:D013095), PVDF (MESH:C024865), ROS (MESH:D017382), chloroquine (MESH:D002738), Calcium (MESH:D002118), sucrose (MESH:D013395), paraformaldehyde (MESH:C003043)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** A to D, Pro23His
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU)

## Figures

11 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12939882/full.md

---
Source: https://tomesphere.com/paper/PMC12939882